Advertisement

Topics

Maxim $VKTX up sharply (~+80%) after announcing positive top-line 12-week P2 data for VK2809,an oral thyroid beta receptor agonist (TRβ), in Non-Alcoholic Fatty Liver Disease (NAFLD) and elevated LDL-C.have reduced risk in model to 30%, from 50% are incr

13:47 EDT 18 Sep 2018 | tgtxdough

Maxim up sharply (~+80%) after announcing positive top-line 12-week P2 data for VK2809,an oral thyroid beta receptor agonist (TRβ), in Non-Alcoholic Fatty Liver Disease (NAFLD) and elevated LDL-C.have reduced risk in model to 30%, from 50% are increasing PT to $28, from $14

Original Article: Maxim $VKTX up sharply (~+80%) after announcing positive top-line 12-week P2 data for VK2809,an oral thyroid beta receptor agonist (TRβ), in Non-Alcoholic Fatty Liver Disease (NAFLD) and elevated LDL-C.have reduced risk in model to 30%, from 50% are incr

NEXT ARTICLE

More From BioPortfolio on "Maxim $VKTX up sharply (~+80%) after announcing positive top-line 12-week P2 data for VK2809,an oral thyroid beta receptor agonist (TRβ), in Non-Alcoholic Fatty Liver Disease (NAFLD) and elevated LDL-C.have reduced risk in model to 30%, from 50% are incr"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Thyroid Disorders
The thyroid is a butterfly-shaped gland in the neck, just above thecollarbone and is an endocrine gland that make hormones. These Thyroid hormones control the rate of many activities in the body, including how fast the body burns calories and how fast th...

Hepatology
Hepatology is the study of liver, gallbladder, biliary tree, and pancreas, and diseases associated with them. This includes viral hepatitis, alcohol damage, cirrhosis and cancer. As modern lifestyles change, with alcoholism and cancer becoming more promi...